Clinuvel Pharmaceuticals
CUV.AX
#7292
Rank
C$0.48 B
Marketcap
$9.75
Share price
-0.27%
Change (1 day)
-26.88%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: C$47 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$59.01 Million. In 2024 the company made an earning of C$47 Million, an increase over its 2023 earnings that were of C$41.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024C$47 M12.42%
2023C$41.81 M27.77%
2022C$32.72 M22.23%
2021C$26.77 M114.01%
2020C$12.5 M-29.03%
2019C$17.62 M32.76%
2018C$13.27 M75.24%
2017C$7.57 M-332.09%
2016-C$3.27 Million-70.52%
2015-C$11.08 Million53.56%
2014-C$7.22 Million-16.31%
2013-C$8.62 Million-37.85%
2012-C$13.87 Million-18%
2011-C$16.91 Million25.86%
2010-C$13.44 Million-21.79%
2009-C$17.18 Million-11.73%
2008-C$19.46 Million80.71%
2007-C$10.77 Million-2.86%
2006-C$11.09 Million-4.95%
2005-C$11.67 Million60.55%
2004-C$7.27 Million97.37%
2003-C$3.69 Million50.62%
2002-C$2.45 Million121.22%
2001-C$1.11 Million254.48%
2000-C$0.32 Million